Henderson A - Search Results

1

Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing Escherichia coli in South Asia.

Islam K, Heffernan AJ, Naicker S, Henderson A, Chowdhury MAH, Roberts JA, Sime FB. Islam K, et al. Among authors: henderson a. Future Microbiol. 2021 May;16:521-535. doi: 10.2217/fmb-2020-0193. Epub 2021 May 7. Future Microbiol. 2021. PMID: 33960818

2

Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Stewart A, Harris P, Henderson A, Paterson D. Stewart A, et al. Among authors: henderson a. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01195-18. doi: 10.1128/AAC.01195-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30104282 Free PMC article. Review.

3

Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.

Paterson DL, Henderson A, Harris PNA. Paterson DL, et al. Among authors: henderson a. Curr Opin Infect Dis. 2020 Feb;33(1):78-85. doi: 10.1097/QCO.0000000000000623. Curr Opin Infect Dis. 2020. PMID: 31834029 Review.

4

Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.

Stewart AG, Harris PNA, Henderson A, Schembri MA, Paterson DL. Stewart AG, et al. Among authors: henderson a. J Antimicrob Chemother. 2020 Sep 1;75(9):2384-2393. doi: 10.1093/jac/dkaa183. J Antimicrob Chemother. 2020. PMID: 32443141

5

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.

Denholm JT, Davis J, Paterson D, Roberts J, Morpeth S, Snelling T, Zentner D, Rees M, O'Sullivan M, Price D, Bowen A, Tong SYC; ASCOT Investigator Group. Denholm JT, et al. Trials. 2020 Jul 14;21(1):646. doi: 10.1186/s13063-020-04576-9. Trials. 2020. PMID: 32665040 Free PMC article.

6

In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.

Stewart AG, Cottrell K, Henderson A, Vemuri K, Bauer MJ, Paterson DL, Harris PNA. Stewart AG, et al. Among authors: henderson a. Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7. Microbiol Spectr. 2021. PMID: 34232101 Free PMC article. Clinical Trial.

7

Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

Coombes ID, Legg A, Patterson T, Kelly T, Henderson A, Roberts JA. Coombes ID, et al. Among authors: henderson a. Aust Prescr. 2022 Apr;45(2):67-68. doi: 10.18773/austprescr.2022.021. Epub 2022 Mar 24. Aust Prescr. 2022. PMID: 35592373 Free PMC article. No abstract available.

8

Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2).

Stewart AG, Paterson DL, Young B, Lye DC, Davis JS, Schneider K, Yilmaz M, Dinleyici R, Runnegar N, Henderson A, Archuleta S, Kalimuddin S, Forde BM, Chatfield MD, Bauer MJ, Lipman J, Harris-Brown T, Harris PNA; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Stewart AG, et al. Among authors: henderson a. Open Forum Infect Dis. 2021 Aug 2;8(8):ofab387. doi: 10.1093/ofid/ofab387. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34395716 Free PMC article.

9

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial.

Stewart AG, Henderson A, Bauer MJ, Paterson DL, Harris PNA. Stewart AG, et al. Among authors: henderson a. JAC Antimicrob Resist. 2021 Dec 28;4(1):dlab192. doi: 10.1093/jacamr/dlab192. eCollection 2022 Mar. JAC Antimicrob Resist. 2021. PMID: 34988445 Free PMC article.

10

Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: A population-based study.

Ratnasekera IU, Johnson A, Powell EE, Henderson A, Irvine KM, Valery PC. Ratnasekera IU, et al. Among authors: henderson a. Medicine (Baltimore). 2022 May 20;101(20):e29217. doi: 10.1097/MD.0000000000029217. Medicine (Baltimore). 2022. PMID: 35608422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,366 results

Search Page